Drug Type Synthetic peptide |
Synonyms- |
Target |
Action antagonists, stimulants |
Mechanism CX3CR1 antagonists(C-X3-C motif chemokine receptor 1 antagonists), Integrin stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Discovery | United States | - |






